BrightPath Biotherapeutics Co.,Ltd. [4594.T]
TOKYO, Jun 25 (Pulse News Wire) – Brightpath Biotherapeutics CO.,LTD. (4594.T) announced today that Director Nakamura Tokuhiko has resigned effective June 25, 2026, due to personal reasons.
Nakamura's resignation does not affect the legal minimum number of directors stipulated by law and the company’s articles of incorporation. Following his departure, the company remains compliant with all regulatory requirements concerning directorship quotas.
The company did not disclose further details regarding the succession plan or any immediate replacements for the vacated position. Management stated that they would ensure smooth operations while adhering to all necessary regulations.
🟢 Confidence: High AI-translated content.